What are clinical trials? What are some of the trials that Norwich scientists have been involved in? What are the challenges involved and why is volunteer participation in clinical trials so vitally important? A panel discussion from those actively involved in getting science out of the lab and into practice.
Recommended ages 12+
Watch live on YouTube and again for 7 days after the event
Set up a YouTube account and log in during the event to join the live chat where you can ask questions and share your thoughts!
Please note that as this is an 'At Home' programme, some contributors may be joining us remotely, and as such the events will not be broadcast standard quality. If there are technical connection issues - please bear with us! Thank you.
Prof Carl Philpott is Professor of Rhinology and Olfactology at the University of East Anglia, and Honorary Consultant Rhinologist in the Norfolk and Waveney Ear Nose and Throat Service. He is currently the Chief Investigator of the NIHR-funded MACRO trial, which was shaped by patient involvement in the trial design. As trustee and director of research and medical affairs for the charity Fifth Sense, he has worked with patients to provide a continued platform for public and patient engagement with research and now leads the James Lind Alliance Priority Setting Partnership for Smell and Taste Disorders.
Sarah Phillips has
been involved in a range of human studies at the Quadram Institute. Sarah is
currently coordinating and managing two large, longitudinal human studies
(the MOTION study and the PEARL study) in the Gut Health and Microbes division,
which look at how the gut microbiome is linked to health at particular times
throughout our lives, such as during pregnancy and early life, and during
Matt Hammond (University of East Anglia) has over 15 years’ experience in the design and delivery of clinical trials. In his current role as Deputy Director of the Norwich Clinical Trials Unit, he oversees a wide portfolio of clinical research projects including drug, medical device and other interventional clinical trials.
Polly Ashford (University of East Anglia) is a senior trials manager at Norwich
Clinical Trials Unit. With a background in antibiotics and organic chemistry
and scientific publishing, she now oversees trials in primary care and mental
health services, and has a particular interest in the use of routinely
collected health data for research.
Dr Rachael Stanley is the
Biorepository (Tissue Bank) Manager at the NNUH. Rachael has an academic
background in musculoskeletal science and microscopy and now oversees the day
to day running of the Biorepository, supporting and advising researchers,
scientists and clinicians on the use of human tissue and data in research.
Andrew Stronach is Head of
External Relations and Engagement at the Quadram Institute. Andrew originally
trained as a journalist and worked as a health correspondent. He has previously
worked in public relations for the University of East Anglia, Norfolk and
Norwich University Hospital, Virgin Money and Aviva. He has also been a
participant in a number of clinical trials on the Norwich Research Park.
Tony Jackson is a Research Champion for the National Institute for Health Research in the Eastern Region and a Patient Research Ambassador for the Norfolk and Norwich University Hospital. He is also a member of the Research Ethics Committee for the UEA Faculty of Medicine and Health, and he is involved with research studies at the Quadram Institute.
We will also be joined
by Nancy Teng, who is a second year PhD student at the Quadram Institute
under the supervision of Dr Lindsay Hall and Dr Stephen Robinson. Before coming
to the Quadram Institute, Nancy completed an MSc in Immunology of Infectious
Disease at the London School of Hygiene and Tropical Medicine. Prior to this,
she graduated from University of East Anglia having studied BSc Biomedicine.
Currently Nancy is working on her PhD project – the BEAM study – which looks
into exploring how the gut microbiota may be involved in breast health and